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Abstract
Background: Variability in processes of care and outcomes has been reported widely in high-income settings
(at geographic, hospital, physician group and individual physician levels); however, such variability and the factors
driving it are rarely examined in low-income settings.
Methods: Using data from a cross-sectional survey undertaken in 22 hospitals (60 case records from each hospital)
across Kenya that aimed at evaluating the quality of routine hospital services, we sought to explore variability in
four binary inpatient paediatric process indicators. These included three prescribing tasks and use of one diagnostic.
To examine for sources of variability, we examined intra-class correlation coefficients (ICC) and their changes using
multi-level mixed models with random intercepts for hospital and clinician levels and adjusting for patient and
clinician level covariates.
Results: Levels of performance varied substantially across indicators and hospitals. The absolute values for ICCs also
varied markedly ranging from a maximum of 0.48 to a minimum of 0.09 across the models for HIV testing and
prescription of zinc, respectively. More variation was attributable at the hospital level than clinician level after
allowing for nesting of clinicians within hospitals for prescription of quinine loading dose for malaria (ICC = 0.30),
prescription of zinc for diarrhoea patients (ICC = 0.11) and HIV testing for all children (ICC = 0.43). However, for
prescription of correct dose of crystalline penicillin, more of the variability was explained by the clinician level
(ICC = 0.21). Adjusting for clinician and patient level covariates only altered, marginally, the ICCs observed in models
for the zinc prescription indicator.
Conclusions: Performance varied greatly across place and indicator. The variability that could be explained
suggests interventions to improve performance might be best targeted at hospital level factors for three indicators
and clinician factors for one. Our data suggest that better understanding of performance and sources of variation
might help tailor improvement interventions although further data across a larger set of indicators and sites would
help substantiate these findings.
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Introduction
Health systems are making efforts to control variation in
care quality to raise overall standards and reduce geo-
graphic inequalities [1,2]. To achieve this, one must first
be able to evaluate quality at scale and then understand
the causes of variation so that these can be rectified. In
resource limited settings, there are few data on quality
of care but these suggest that quality of care varies
greatly across place [3,4]. These wide variations and the
factors driving them are, however, rarely examined in
low-income settings. In higher income settings, variation
in care has been associated with geographic regions or
communities [5,6], hospitals or primary care units [7]
and physicians [1]. However, few studies explore vari-
ability across more than one level [8,9] and most exam-
ine variability in mortality which while objective, may
not be a good indicator of quality of care provided
during any immediate pre-terminal events [10-12]. To
examine quality of services, it may be more pertinent to
examine indicators of the process of care for variability.
The aim of this work is to explore the degree to which
variability in performance of important, recommended
practices (indicators of process of care) is associated
with the organisational units (hospitals) providing care
or potentially attributable to variation between individ-
ual clinicians. We use data from Kenya where there have
been efforts to improve paediatric hospital care through
the development and distribution of evidence-based clin-
ical guidelines for some years [13]. Although these ef-
forts have resulted in some overall improvements, [14]
considerable variability still remains [4]. Understanding
such variation may help inform future interventions to
promote improved care at scale.
Methods
Context
The availability and adoption of multi-level modelling
(MLM) techniques in health care have made it possible
to explore and attribute variation at different levels of
aggregation of healthcare data. Multi-level models allow
for components of variance analysis and estimation of
intra-class correlation coefficients (ICC). The ICC may
be used as a measure of total variation in a performance
measure in a patient population that can be apportioned
to one or more aggregated levels in a model. High ICCs
suggest a strong within group correlation of individual
observations and large group effects, while small ICCs
suggest that observations are similar to independent
observations (suggesting no group or clustering effect)
[15]. From a health service improvement perspective,
therefore, a high ICC suggesting considerable variability
in performance associated with a level of aggregation
may make the level a key target for improvement efforts
when considered together with the absolute level of
performance [16]. In this work, we are using ICCs for
the purposes of exploring sources of variation in care in
Kenyan hospitals recognising that many interventions
aiming to promote adoption of new practices, particu-
larly education and training, focus on individual health
workers.
Survey sites, data collection and sample size
Data used were from a cross-sectional survey of 22
‘internship training centres’ (hereafter referred to as hos-
pitals) purposively identified by the Ministry of Health
from a total population of 40 ‘internship training centres’
seeking an administratively and geographically represen-
tative sample across Kenya. In brief, the aim of the par-
ent study was to undertake a comprehensive assessment
that compared the current practices in internship train-
ing hospitals with evidence-based guidelines with an
intention of identifying priority areas in need of im-
provement and to provide recommendations on strat-
egies to improve care. The parent study (described in
full elsewhere, [4,17]) aimed at retrieving 60 paediatric
inpatient case records per hospital for retrospective chart
review. This would allow reporting 50% to 10% correct
performance across hospitals with a precision of ±7.5%,
adjusted for clustering within hospitals, with a minimum
of 12 to 4 cases, respectively, for predefined disease-
specific indicators. This approach also meant that the
distribution of cases with different diagnoses (case mix)
varied across hospitals due to their epidemiological diver-
sity (see Table 1). Each patient record was linked to a spe-
cific hospital code and assigned a unique, anonymous
clinician code linking patients seen by specific clinicians
within each hospital. This clinician code was linked to a
separately collected database containing clinician charac-
teristics (age group, cadre-clinical officer, medical officer/
paediatrician, work duration and gender). The available
case records per hospital, total clinicians and average pa-
tients per clinician for each of the disease-related indica-
tors of interest are presented in Table 1.
Process indicators
We identified process indicators linked to common and
important diagnoses in Kenyan hospitals [18,19] repre-
senting tasks that are expected functions of the admit-
ting clinician and for which there are clear standards for
clinical compliance. Specifically, we sought to explore
the variability in three prescribing indicators that in-
cluded the following: i) prescription of a quinine loading
dose for children with malaria; ii) prescription of correct
dose per kilogram body weight of crystalline penicillin
for children with pneumonia; iii) prescription of zinc for
children with diarrhoea/dehydration; and separately, one
diagnostic indicator, HIV testing for all children admitted
to hospital as is required by national policy. Confirmation
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of the availability of these drugs or diagnostic tests in the
hospitals studied at the time of survey has previously been
reported [4].
Covariate definitions
Age was categorised into 2–11 and 12–59 months as most
guideline recommendations use these age cut-offs. The
number of diagnoses made at admission (co-morbidities)
was categorised into no co-morbidity (4% (52)), one co-
morbidity (49% (635)), two co-morbidities (37% (477)) and
three to five co-morbidities (10% (134)). For clinician char-
acteristics, cadre was collapsed into the main cadres in
hospitals, clinical officers (62%; 180/291) and medical offi-
cers (38%; 181/291 which included 3 clinicians with spe-
cialised paediatric training). Similarly, only 16% (46/290)
of the clinicians had 2 or more years’ experience; there-
fore, experience was coded as a binary variable rep-
resenting internship (0–1 year, 244 (84%)) and post
internship (2 or more years, 46 (16%)).
Analysis
We initially present overall proportions across hospitals
and accompanying 95% confidence intervals (CI) ad-
justed for clustering at the hospital level for each of the
four indicators to illustrate aggregate performance and
variability across sites. Subsequently, multi-level mixed
models are fitted to explore whether the variability in
performance observed is primarily driven by hospital
level factors and differences in performance between cli-
nicians in each hospital or is associated with patient
level factors. For this, we used a nested model of pa-
tients within clinicians within hospitals.
For each of the indicators, four models were specified.
The first (model 1) was a two-level model of patients
within hospitals with no covariates. The second model
(model 2) was a three-level model of patients nested
within clinicians nested within hospitals with no covari-
ates that aimed to demonstrate the overall variability at
hospital and clinician levels combined. In the third
model (model 3), we introduced patient level covariates
to model 2 as fixed effects in three separate steps to ex-
plore the effect of case mix on the variability observed:
a) Step 1 - Age and gender were added because they are
not influenced by either hospital or clinician behaviour,
b) Step 2 - Disease severity and co-morbidity were added
because these may vary by hospital and their presence
may influence clinician behaviour, c) Step 3 - All patient
level covariates, disease severity, co-morbidity, age and
gender, were added to explore the overall effect of pa-
tient level covariates. However, for HIV testing which is
a diagnostic indicator, disease severity was not included.
Finally, in the last model (model 4), we explored the im-
pact of clinician characteristics (gender, age and experi-
ence) by adding these as fixed effects to model 2 (first,
separately and then all together). Likelihood ratio tests
(LRT) were used to compare models 3 and 4 against
model 2 to explore whether adding any of these fixed ef-
fects improved overall model fit. We also examined the
magnitude of change in the ICCs to try and understand
how levels and covariates contributed to the variability
explained by the models. We present ICC estimates
representing total variability explained by the model;
therefore, changes in ICC estimates observed after add-
ing the clinician level demonstrate the additional vari-
ability explained by the clinician level after allowing
nesting of clinicians within hospitals (the difference in
ICC estimated in the models with (model 2) and without
(model 1) clinicians). In the same way, we can contrast
the ICCs from models 3 and 4 with model 2 when fixed
effects are introduced. Although we did not have any
formal reference point to decide if the ICC had changed
to an important degree, we considered absolute changes
Table 1 Distribution of cases across indicators
Outcome 1 Outcome 2 Outcome 3 Outcome 4
Prescription of quinine
loading dose for malaria
Dosing accuracy of crystalline
penicillin for pneumonia
Prescription of zinc for
diarrhoea or dehydration
HIV testing for all
admitted patients
Total case available 433 597 271 1298
Total cases with clinician data (%) 368 (85%) 468 (78%) 206 (76%) 1036 (80%)
Hospitals (No.) 19a 22 22 22
Mean n° of cases per hospital 20 27 12 59
Range of cases per hospital 1–51 13–39 4–27 54–61
Clinicians (No.) 187 226 153 337
Proportion of clinicians with one case 27% 19% 16% 34%
Mean n° of clinicians across hospital 8.5 10 7 15
Range of clinicians across hospital 1–26 3–21 3–11 5–30
Range of cases per clinician 1–11 1–20 1–10 1–46
aThree sites in non-malaria endemic areas had no cases.
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of more than 25% at a level after including a fixed effect
as a change of possible interest. For a subset of cases
varying between 24% and 15% across the indicators (see
Table 1), it was difficult to link case records with data on
the clinician characteristics. Therefore, caution is re-
quired when interpreting the comparison of model 2
and model 4 ICC estimates as there were differences in
the number of observations.
The XTMELOGIT procedure in Stata version 13 for
binary outcomes was used for multi-level modelling.
The ICCs were calculated using the latent variable
method supported by Snijders and Bosker that converts
the level 1 variance from the probability scale to the
logistic scale on which level 2 (clinician) and level 3
(hospital) are expressed. The standard logistic distribu-
tion has a variance of π2/3 = 3.29; hence, this can be
taken as the level 1 variance. Since levels 1, 2 and 3 vari-
ances are on the logistic scale, the following formula was
used to estimate ICC at different levels:
ICChospital ¼ variancehospital= variancehospital

þ varianceclinician þ 3:29Þ
ICCclinician and hospital ¼ varianceclinician þ variancehospital
 
=
variancehospital þ varianceclinician

þ 3:29Þ:
To provide plausible ranges of ICC estimates around
each estimate, 95% confidence intervals (CI) around the
ICCs were constructed using a normal approximation of
the logit transformation of the ICC estimates.
Results
The overall performance for indicators pooled across
hospitals is reported in Table 2 and was above 65% for
the prescription indicators but poor for HIV testing at
12%. Performance at hospital level varied greatly across
all four indicators (although small sample sizes were ob-
served at hospital level for quinine and zinc indicators),
for instance, zinc prescription ranged between 29% and
92% amid the best and worst hospitals, while HIV test-
ing for all admitted children ranged from 0% to 47%.
We observed quite different patterns across the indica-
tors for the proportion of variability explained by the
different levels in the models. We thus discuss the
variability observed for each indicator across the differ-
ent levels separately with the detailed results on the ICC
estimates across the different levels and indicators being
presented in Table 3. For models 3 and 4, only models
including all covariates at patient and clinician levels will
be presented because the full model with all covariates
was at least as good a fit as partial models with no ap-
preciable difference in ICC results.
In the models for prescription of quinine loading dose,
the majority of the variability that can be explained by
the model is at the hospital level. However, the total
variability explained after allowing for nesting of clini-
cians within hospitals (model 2, ICC estimate of 0.40) in-
creased compared with that of model 1 (ICC estimate of
0.30). This suggests the clinician level also explains a
sizeable amount of the total variability observed. Adjust-
ing for patient level and clinician level covariates did not
alter this interpretation on the sources of variability.
Comparing ICC estimates from model 1 (ICC = 0.07)
and model 2 (ICC = 0.26) for prescription of correct dose
of crystalline penicillin, more of the total variability ob-
served could be attributed to the clinician level. Inclusion
of patient level and clinician level covariates again did not
result in substantial changes in the ICC estimates.
For prescription of zinc for diarrhoea patients, the
variability explained by the models was generally low
with more of the variability observed attributable to the
hospital level. Adjusting for patient level covariates re-
sulted in 25% change in ICC (from 0.11 to 0.14) suggest-
ing that patient level covariates may help explain
variability better, and the ICC increased through reduc-
tion of the residual variability in the model. However,
there was no evidence that adjusting for clinician level
covariates explained variability better.
All of the variability observed for HIV testing of chil-
dren admitted was at the hospital level. Further, there
was no evidence that adjusting for patient level and clin-
ician level covariates explained variability better.
Overall, the effect of patient level covariates on the
proportion of variability associated with a level varied
across indicators. However, across all outcomes, there
were no absolute changes in ICCs of greater than 25%
after adjusting for patient level covariates except for zinc
prescription. Similarly, after adjusting for clinician level
Table 2 Performance of the various outcomes pooled across hospitals
Indicator Cases available n (% [95% CI]) Median (IQR) for hospital
specific proportions
Range hospital specific
estimates
Quinine loading dose for malaria patients* 433 320 (74 [62–83]) 72 [30–86] 0 to 100
Zinc prescription for diarrhoea/dehydration 271 179 (66 [57–74]) 62 [53–80] 29 to 92
Correct crystalline penicillin dose for pneumonia 597 395 (92 [88–95]) 95 [90–100] 77 to 100
HIV testing for all admitted children 1298 156 (12 [7-19]) 8 [2-16] 0 to 47
aFrom 19 out of the 22 hospitals.
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covariates, only marginal changes in ICCs were ob-
served. Although there were differences in the ICC esti-
mates between model 2 and model 4, these differences
may have arisen due to varying numbers of observations
between these two models. However, restricting analyses
of both models to complete cases provided similar re-
sults (data not shown).
Discussion
The primary purpose of this analysis was to explore vari-
ability in performance of important recommended clin-
ical practices, captured as process indicators that may be
associated with organisational units (hospitals), indi-
vidual clinicians, or with individual patients. We also
explored whether this variation in performance was
Table 3 Intra-class correlation coefficients for total variability explained by the model for various levels and covariate
adjustments across indicators
Model Model specific ICC estimate (95% CI)
Prescription of quinine loading dose for malaria patients
Two level models with no covariates (model 1)
Hospital level (ignoring clinician) 0.30 (0.15–0.45)
Nested model with no covariates (model 2)
Nested model of clinicians within hospitals 0.40 (0.20–0.64)
Nested model with fixed effects for patient characteristics (model 3)
Age, gender, severity and co-morbidity 0.43 (0.22–0.66)
Nested model with fixed effects for clinician characteristics (model 4)
Gender, experience and cadrea 0.36 (0.15–0.65)
Prescription of correct dose of crystalline penicillin for pneumonia patients
Two level models with no covariates
Hospital level (ignoring clinician) 0.07 (0.01–0.44)
Nested model with no covariates
Nested model of clinicians within hospitals 0.26 (0.05–0.68)
Nested model with fixed effects for patient characteristics
Age, gender, severity and co-morbidity 0.23 (0.04–0.68)
Nested model with fixed effects for clinician characteristics
Gender, experience and cadrea 0.26 (0.05–0.72)
Prescription of zinc for diarrhoea patients
Two level models with no covariates
Hospital level (ignoring clinician) 0.09 (0.03–0.27)
Nested model with no covariates
Nested model of clinicians within hospitals 0.11 (0.02–0.46)
Nested model with fixed effects for patient characteristics
Age, gender, severity and co-morbidity 0.14 (0.01–0.63)
Nested model with fixed effects for clinician characteristics
Gender, experience and cadrea 0.10 (0.03–0.33)
HIV testing for all children admitted
Two level models with no covariates
Hospital level (ignoring clinician) 0.43 (0.24–0.64)
Nested model with no covariates
Nested model of clinicians within hospitals 0.43 (0.24–0.64)
Nested model with fixed effects for patient characteristics
Age, gender and co-morbidity 0.42 (0.24–0.63)
Nested model with fixed effects for clinician characteristics
Gender, experience and cadrea 0.48 (0.27–0.70)
aModel 4 has fewer observations due to missing clinician characteristic data.
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consistent across different process indicators. The abso-
lute values for ICC varied markedly ranging from 0.48 to
0.08 across the models developed for HIV testing and
prescription of zinc, respectively. For prescription of
quinine loading dose, prescription of zinc and HIV test-
ing, the hospital level was associated with most of the
variability that could be explained by models even after
allowing nesting of clinicians within hospitals. However,
for prescription of quinine, an appreciable amount of
variability was explained by the clinician level, while for
the prescription of crystalline penicillin, most of the vari-
ability explained was at the clinician level.
What are the causes of the different patterns of ob-
served variation in our study? For HIV testing where the
government policy is that all children admitted to hos-
pital should be tested for HIV, there was no evidence of
any variability at the clinician level. Anecdotal evidence
and prior work [13] suggest that supportive supervision
and commitment of the hospital leadership to enforce
such policies are important in adoption since testing kits
are rarely missing in hospitals and were available at the
time of study [4]. However, it is also clear that where
performance is zero in a facility (as it was in five hos-
pitals for this indicator), there can be no clinician
dependent variability. Arguably, for common recom-
mended prescription tasks such as for Zinc and quinine
loading dose, differences in local leadership and super-
vision may explain the predominance of hospital level
effects explaining variability. Conversely, more of the
observed variability for prescription of correct dose of
crystalline penicillin was at the clinician level, and the
potential explanation is that the accuracy of dosing cap-
tured by this indicator perhaps reflects a task that re-
quires a greater cognitive effort from the clinician in
paediatrics as it is a weight-based calculation.
Planning interventions need to be informed by the ab-
solute levels of performance but, we argue, may also be
informed by understanding of the sources of variability.
The heterogeneity in the sources of variability across in-
dicators suggests potential areas or levels to target for
intervention or quality improvement initiatives. Consid-
erable variability explained at hospital level may suggest
that interventions aimed at whole organisations are
needed, while variability explained at clinician level
nested within hospitals may suggest that targeting both
hospitals and individual clinicians is required. For in-
stance, it would not seem sensible to rely on clinician
training to improve the uptake of HIV testing, particu-
larly training of the type often used in low-income set-
tings of calling individual clinicians to attend centralised,
knowledge-focused courses. Thus, perhaps, these data
help explain why educational interventions often have
modest impacts [20,21]. As a consequence, our findings
suggest we should consider more often the complexity
of changing practice [13] and interventions that change
the way teams and organisations work acknowledging
the different factors that explain behaviour [22].
Most ICC estimates from low-income settings are
from clinical trials [5,6] and community [5] settings. In
the present study, we aimed to describe the distribution
of ICCs in routine care using observational data and to
evaluate factors that influence the magnitude of ICCs.
The estimates we report are relatively high compared to
those reported at hospital level in high-income settings
(typical ICC < 0.05 in a review by Adams and colleagues
[23]). However, they are more consistent with ICC esti-
mates reported across process indicators in low-income
settings by Taljaard (median ICC = 0.09) and Haddad
(median 0.16 (interquartile range (IQR) 0.07–0.32))
[24,25]. There were no notable difference in ICCs after
adjusting for case mix in our study in contrast with the
existing literature [16,26], although this largely deals
with studies on chronic illnesses with clinically heteroge-
neous populations [16,27,28].
Strengths
Our study provides ICC estimates for the acute illness epi-
sodes we examined at hospital level that are often lacking
for low-income settings. Availability of these estimates
should help inform sample size and power calculations for
appropriate study designs addressing a recognised chal-
lenge of extrapolating ICC estimates to different contexts
[29,23]. Secondly, our sample of 22 hospitals is arguably
large compared to other studies on quality of care assess-
ment in low-income settings. Finally, by demonstrating
the sources of variation, this study highlights the need to
understand practice variation in order to target interven-
tions better.
Limitations
The data we report needs to be interpreted in light of
the following limitations. Firstly, this is exploratory work
based on a relatively small number of sites, observations
and indicators. Paterson and Goldstein suggest at least
25 observations from 25 clusters [30], while Donner and
Klar recommend at least 40 clusters [31] for meaningful
interpretation. Our estimates from 22 clusters therefore
need to be interpreted with caution, and there are fur-
ther challenges when attempting to estimate variability
at the clinician level as 16% to 34% of the clinicians
contributed just one observation per indicator. Similar
challenges in reliably estimating variability have been re-
ported by Fung [32] and Huang [33]. We also intro-
duced hospitals as a random term although hospitals
were not from a random sample. However, we tested the
validity of this approach by undertaking the Hausman
specification test [34,35] that provided evidence to sup-
port this approach across all outcomes.
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Conclusion
Care varies greatly across places with considerable het-
erogeneity in performance across indicators. More of the
variability observed could be explained by hospital than
clinician levels, suggesting that interventions aimed at
whole organisations may often be more useful than
those directed at individual clinicians such as training,
although variability amongst individual clinicians may be
important to performance in some areas. This type of
multi-level analysis may therefore prove useful for recog-
nising sources of variability and suggesting how to target
interventions. However, more data across a larger set of
indicators and sites are required to better understand
variability and substantiate our findings.
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